Company Filing History:
Years Active: 1996-2002
Title: Innovations by James A. Hoffman
Introduction
James A. Hoffman is a notable inventor based in Greenwood, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for diabetes and obesity. With a total of 2 patents, Hoffman's work has the potential to impact the lives of many individuals suffering from these conditions.
Latest Patents
Hoffman's latest patents include "Glucagon-like insulinotropic peptides, compositions and methods." This invention provides novel complexes consisting of certain GLP-1 molecules associated with a divalent metal cation. These complexes are capable of co-precipitating with a GLP-1 molecule. The pharmaceutical compositions and methods of using such complexes aim to enhance the expression of insulin in B-type islet cells. This invention also claims a method for treating maturity onset diabetes mellitus in mammals, particularly humans. Another significant patent is for "Anti-obesity proteins." This invention provides anti-obesity proteins that, when administered to a patient, regulate fat tissue. Such agents allow patients to overcome their obesity handicap and live normal lives with a much-reduced risk for type II diabetes, cardiovascular disease, and cancer.
Career Highlights
James A. Hoffman is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its innovative research and development. His work at Eli Lilly has allowed him to focus on groundbreaking research that addresses critical health issues.
Collaborations
Hoffman has collaborated with notable colleagues, including John A. Galloway and Richard Dennis DiMarchi. These collaborations have contributed to the advancement of his research and the development of effective treatments.
Conclusion
James A. Hoffman is a distinguished inventor whose work in pharmaceuticals has led to significant advancements in diabetes and obesity treatment. His innovative patents reflect his commitment to improving health outcomes for patients.